Randomized Study of Plasmapheresis or Human Immunoglobulin Infusion in Childhood Guillain-Barre Syndrome
Status:
Terminated
Trial end date:
2002-11-01
Target enrollment:
Participant gender:
Summary
OBJECTIVES:
I. Compare the efficacy of plasmapheresis and human immunoglobulin infusion in minimizing
morbidity and augmenting the pace of recovery in children with Guillain-Barre syndrome.
II. Compare the potential risks, in terms of treatment related side effects and adverse
clinical outcome, between these two treatment modalities.